- 4 days & nights inpatient stay
- 4 quick follow-up appointments
This clinical trial has been approved by an independent ethics committee.
About the study
One of the biggest risks for cancer patients receiving life-saving stem cell treatments such as bone marrow transplants is Graft-Versus-Host Disease. The ‘donated stem cells’ (once transplanted to their new body) may recognise the patient as ‘foreign’, and attack the healthy tissues and organs, leading to tissue damage and potential organ failure. When this happens – This condition is called “Graft-Versus-Host Disease” or GVHD and it is very difficult for doctors to treat.
This new medication has been developed as a potential treatment for GVHD as there are limited treatment options for patients who develop this serious condition.
Volunteers will be reimbursed for their time and inconvenience for participating in this study.
How do I find out more?
If you have already registered with us but would like more information about this study, please call 1800 243 733 or schedule a call back. You can also email us at firstname.lastname@example.org quoting “Hero Study”.
If you are interested in participating and have not previously registered as a participant with us, fill in your details in the form below and we’ll be in touch soon!